Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tonix Pharmaceuticals

Tonix Pharma's Drug Gets FDA Nod For Chronic Pain Condition, First New Therapy In Over 15 Years

On Friday, the U.S. Food and Drug Administration (FDA) approved Tonix Pharmaceuticals Holding Corp.’s (NASDAQ:TNXP) Tonmya (cyclobenzaprine HCl sublingual tablets) for fibromyalgia in adults.

Benzinga

What's Going On With Tonix Pharmaceuticals (TNXP) Stock?

Shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) have rallied 30% over the past five sessions, though are marginally lower Thursday afternoon, as investors anticipate a key catalyst for the company.

Benzinga

Why Tonix Pharmaceuticals (TNXP) Stock Is Climbing This Week

Shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) are building on recent gains, trading higher as investor focus intensifies on a key, upcoming catalyst. Here’s what investors need to know.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Tonix Pharmaceuticals (TNXP) Stock Surges On Q2 Earnings Beat And Upcoming FDA Catalyst

Shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) are trading sharply higher Tuesday morning following the release of the company’s second-quarter financial results and operational update.

Benzinga

Pharma Frenzy: Volatility Ignites Biotech Sector

Two biotech companies have surged on recent developments, illustrating biotech's volatility and prompting investors to evaluate potential long-term value.

MarketBeat

Is Tonix Pharmaceuticals the Next Biotech Breakout?

Tonix Pharmaceuticals' innovative approach to fibromyalgia treatment positions the company for substantial market disruption and long-term growth.

MarketBeat

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ:PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D). Insulet shares traded in a range of $260.13 to $266.73 on day volume of 200.86 thousand shares…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary

Avalo Therapeutics (NASDAQ:AVTX) has dosed the first patient in the pivotal LADDER trial to assess the efficacy and safety of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II (LAD II) ER). Avalo shares traded in a range of $3.5 to $3.91 on a day volume of 33.54 thousand shares,…

Benzinga

What's Going On With Tonix Pharmaceuticals Shares Today?

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower by 6.03% to $2.96 during Thursday’s pre-market session. The company announced Thursday that it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq.

Benzinga

EXCLUSIVE: Tonix CEO Seth Lederman On The Pursuit Of New Monkeypox, COVID Vaccines

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a Chatham, New Jersey-based clinical-stage biopharmaceutical company, announced on Wednesday the issuance of a patent that forms the basis for the company's developmental vaccine against monkeypox and smallpox.

Benzinga

Recap: Tonix Pharmaceuticals Q1 Earnings

Tonix Pharmaceuticals (NASDAQ:TNXP) reported its Q1 earnings results on Monday, May 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022

Upgrades

Benzinga

Tonix Pharmaceuticals Rockets Higher Thursday: Why Is The Penny Stock Flying?

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares are rallying higher Thursday after the company announced the FDA has granted Orphan-Drug Designation for TNX-2900 for the treatment of Prader-Willi syndrome.

Benzinga

Tonix Pharma Inks Research Pact For Oxytocin In Eating Disorder

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

People

Anthony Fauci

570 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.